WATSON 617 Pill - gray round, 8mm
Pill with imprint WATSON 617 is Gray, Round and has been identified as Morphine Sulfate Extended Release 100 mg. It is supplied by Watson Laboratories, Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 100 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 617
Morphine Sulfate Extended Release
- Imprint
- WATSON 617
- Strength
- 100 mg
- Color
- Gray
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-0617 (Discontinued)
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (366)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine Extended-Release Capsules
- Morphine Immediate-Release Tablets and Capsules
Other brands
MS Contin, Kadian, MorphaBond ER, Roxanol, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Kadian, MorphaBond ER, Duramorph, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.